Equity trading on Friday produced pronounced headline movers from the biggest market-cap names down through small caps. Several individual corporate developments - from a regulator opinion to company results and a dividend declaration - dominated the price action for the most volatile names of the session.
Mega-cap movers
- SanDisk Corp-Exch (SNDK) fell 4.98%.
- Dell Inc (DELL) declined 4.35%.
- Marvell Technology Group Ltd (MRVL) dropped 5.29% - Marvell also declared a quarterly dividend of $0.06 per share.
These large-cap moves were driven by discrete corporate items rather than broad market themes. Marvell's share decline came on the same session that the company announced its $0.06 quarterly dividend, while SanDisk and Dell posted sharper downside without additional context in the session summary.
Large-cap stock movers (market cap $10-$200 billion)
- Tower Semiconductor (TSEM) slid 9.0%.
- Entegris Inc. (ENTG) slipped 8.77%.
- New Providence Acquisition Corp N (ASTS) gained 8.52%.
- Moderna (MRNA) rallied 10.93%.
Within the large-cap cohort, Moderna posted the session's strongest percentage advance, while a pair of semiconductor-related names moved lower by high single-digit percentages. A special purpose acquisition vehicle also recorded a notable uptick.
Mid-cap stock movers (market cap $2-$10 billion)
- TransMedics Group Inc (TMDX) tumbled 13.02%.
- PDF Solutions (PDFS) fell 6.62%.
- Biohaven Pharmaceutical Holding Co (BHVN) climbed 7.53%.
The mid-cap band included both substantial declines and a meaningful advance in a pharmaceutical name, reflecting the ongoing dispersion across healthcare and technology-related mid-sized companies.
Small-cap stock movers (market cap $300 million - $2 billion)
- Omeros Corp (OMER) plunged 19.5% after a European regulator issued a negative opinion on Omeros' TA-TMA drug.
- LITX (LITX) dropped 16.28%.
- Capricor Therap (CAPR) slid 13.63% after the company reported five-year data for its Duchenne therapy deramiocel.
- AAOX (AAOX) fell 10.91%.
- Apogee Enterprise (APOG) rose 13.91%; the company beat estimates but provided guidance below street views.
- Galena Biopharma (SLS) advanced 11.18%.
- Pulse Biosciences Inc (PLSE) added 6.96%.
- FuelCell Energy (FCEL) surged 21.22%.
Small-cap activity on Friday was dominated by biotech and specialty technology names. Regulatory feedback significantly weighed on Omeros, while Capricor's market reaction followed the release of five-year clinical data. Conversely, a handful of smaller companies posted double-digit gains, including FuelCell Energy and Apogee Enterprises, the latter after beating estimates but flagging guidance that fell short of analyst expectations.
Takeaways
- Company-specific developments - regulatory opinions, clinical data releases, earnings and guidance, and dividend declarations - were the primary drivers of the largest percentage moves across market-cap segments.
- Healthcare and semiconductor-related names saw some of the largest intraday dispersion, impacting mid- and small-cap universes particularly hard.
- Both high single-digit and double-digit percentage moves were observed, underscoring the uneven nature of the session across sectors and market-cap groups.